ABSTRACT
To date, many potent compounds have been found which are derived from plants and herbs and possess anticancer properties due to their antioxidant effects. 9â³-Lithospermic acid methyl ester is an effective natural compound derived from the Thymus thracicus Velen. It has been proven that this compound has substantial properties in different diseases, but its effects in cancer have not been thoroughly evaluated. The aim of this work was to study the effects of 9â³-Lithospermic acid methyl ester (9â³-methyl lithospermate) in U87 and T98 glioblastoma cell lines. Its effects on cellular viability were assessed via Trypan Blue and Crystal Violet stains, the cell cycle analysis through flow cytometry, and cell migration by employing the scratch wound healing assay. The results demonstrated that 9â³-methyl lithospermate was able to inhibit cellular proliferation, induce cellular death, and inhibit cell migration. Furthermore, these results were intensified by the addition of temozolomide, the most prominent chemotherapeutic drug in glioblastoma tumors. Further studies are needed to reproduce these findings in animal models and investigate if 9â³-lithospermic acid methyl ester represents a potential new therapeutic addition for gliomas.
Subject(s)
Antineoplastic Agents , Benzofurans , Brain Neoplasms , Depsides , Glioblastoma , Animals , Glioblastoma/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Temozolomide/pharmacology , Benzofurans/pharmacology , Cell Proliferation , Cell Line, Tumor , Apoptosis , Brain Neoplasms/drug therapy , Brain Neoplasms/pathologyABSTRACT
Radiotherapy may be used alone or in combination with chemotherapy for cancer treatment. There are many mechanisms of radiation treatment exposure to toxicities. Our aim was to summarize the literature about known mechanisms of radiation-induced cardiac toxicities. We performed a systematic review of the literature on the PubMed database until October 2022 about cardiovascular toxicities and radiation therapy exposure. Only systematic reviews, meta-analyses, and reviews were selected. Out of 1429 publications screened, 43 papers met inclusion criteria and were selected for the umbrella review process. Microvascular and macrovascular complications could lead to adverse cardiac effects. Many radiotherapy-associated risk factors were responsible, such as the site of radiation treatment, beam proximity to heart tissues, total dosage, the number of radiotherapy sessions, adjuvant chemotherapeutic agents used, and patient traditional cardiovascular risk factors, patient age, and gender. Moreover, important dosage cutoff values could increase the incidence of cardiac toxicities. Finally, the time from radiation exposure to cardiac side effects was assessed. Our report highlighted mechanisms, radiation dosage values, and the timeline of cardiovascular toxicities after radiation therapy. All of the above may be used for the assessment of cardiovascular risk factors and the development of screening programs for cancer patients.
Subject(s)
Cardiotoxicity , Neoplasms , Humans , Cardiotoxicity/etiology , Heart/radiation effects , Neoplasms/drug therapy , Neoplasms/radiotherapy , Neoplasms/complications , Risk Factors , Radiation DosageABSTRACT
Background and Objectives: Previous studies revealed the anti-angiogenic, antiproliferative, and anti-inflammatory effects of Vitamin D (VitD) on cancer cells. Although this body of evidence supported the correlation of high VitD levels with reduced incidence rates for various malignancies, contradictory results were reported regarding non-melanoma skin cancer (NMSC). The aim of this overview was to summarize the available evidence from the existing pool of systematic reviews and meta-analyses, focusing on VitD serum status, dietary intake, and VitD receptor (VDR) polymorphisms in correlation to NMSC incidence. Materials and Methods: A literature search in electronic databases was conducted from inception to January 2023. The inclusion criteria were systematic reviews and meta-analyses published in peer-reviewed journals, evaluating VitD serum levels, dietary and/or supplementary intake, or VDR gene polymorphisms, and reporting data on NMSC. Results: A total of 10 studies were included in the data analysis models. A positive association between VitD serum levels and NMSC is highlighted. However, dietary/supplementation of VitD does not exhibit a likewise strong linkage to NMSC. Despite the contradictory findings, VDR polymorphisms may play a crucial role in the intricate NMSC pathogenesis. Conclusions: This umbrella review shows that high VitD levels are associated with increased NMSC incidence, potentially due to its direct correlation with increased sun exposure. Further research on VDR polymorphisms is suggested to explore their true effect size on NMSC risk.
Subject(s)
Skin Neoplasms , Vitamin D , Humans , Systematic Reviews as Topic , Vitamins , Skin Neoplasms/epidemiology , Skin Neoplasms/etiology , Receptors, Calcitriol/genetics , Polymorphism, GeneticABSTRACT
Patients with illicit drug use may have deleterious acute and chronic cardiac effects. We present a case of a 42-year-old man, former alcohol and various illicit drugs user, who was admitted to the psychiatric unit for management of psychosis. Because of his previous drug and alcohol history, a cardiological evaluation was performed which revealed silent severe myocardial ischemia detected by myocardial perfusion imaging (MPI). The myocardial ischemia was attributed to coronary microvascular dysfunction, occurring several years after quitting the illicit drugs. This study highlights the potential myocardial ischemia that may occur in patients with previous alcohol and illicit drug use, and the role of MPI, a non-invasive test that can provide important information regarding the myocardial status of such patients, even without obvious cardiac symptoms or findings.
Subject(s)
Coronary Artery Disease , Illicit Drugs , Myocardial Ischemia , Myocardial Perfusion Imaging , Male , Humans , Adult , Illicit Drugs/adverse effects , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/etiology , Myocardial Perfusion Imaging/adverse effects , Myocardial Perfusion Imaging/methodsABSTRACT
Background and Objectives: Obesity has been linked to various cardiovascular risk factors, increased incidence of coronary artery disease, and myocardial perfusion defects. The aim of this study was to investigate if body mass index (BMI) and waist circumference (WC) were associated with myocardial perfusion defects. Materials and Methods: A total of 308 consecutive patients who had myocardial perfusion imaging (MPI) with single photon emission computed tomography (SPECT) and a complete medical record on file were studied retrospectively. Results: The median age was 69 (61−76) years, the BMI was 27.6 (24.4−30.7) kg/m2, and the WC was 110 (102−118) cm. Of the 308 patients, 239 patients (77.6%) had myocardial ischemia. A positive test for ischemia was more frequent in men compared to women (72 vs. 28%, p < 0.001). Within the male group, BMI and WC were not significantly different between the ischemia and non-ischemia groups. In contrast, within the female group, both BMI (30.2 vs. 27.1 kg/m2, p = 0.002) and WC (112 vs. 105.5 cm, p = 0.020) were significantly higher in the ischemia group. Multivariable logistic regression showed that male sex and BMI were the only two independent predictors of ischemia in our patient population. Conclusions: This study showed that BMI was an independent predictor of ischemia in our patient population.
Subject(s)
Coronary Artery Disease , Myocardial Ischemia , Myocardial Perfusion Imaging , Aged , Body Mass Index , Coronary Artery Disease/complications , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/epidemiology , Female , Humans , Male , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/epidemiology , Myocardial Ischemia/etiology , Myocardial Perfusion Imaging/methods , Retrospective Studies , Risk FactorsABSTRACT
Background and Objectives: Vitamin D (Vit D) deficiency has been implicated in various conditions, including cardiovascular disease. The purpose of this retrospective study was to investigate the incidence of patients with myocardial ischemia in relation to their serum levels of vitamin D. Materials and Methods: A 64-month search (January 2016 to April 2021) in our database of the Nuclear Medicine Laboratory revealed 113 patients who had both myocardial perfusion imaging with single photon emission computed tomography (MPI SPECT) and Vit D measurements. MPI SPECT obtained myocardial images during both stress (summed stress score, SSS) and rest (summed rest score, SRS). Abnormal MPI SPECT was when the SSS was ≥4. Vit D was determined by radioimmunoassay (RIA). Patients with Vit D values <10 ng/mL, 10-29 ng/mL and ≥30 ng/mL were defined as having a deficiency, insufficiency and sufficiency, respectively. Results: Among patients, 46/113 (40.7%) were male and 67/113 (59.3%) were female. Abnormal MPI was found in 58/113 (51.3%) patients. Vit D deficiency was noted in 20/113 (17.7%) patients, insufficiency in 86/113 (76.1%) patients, and normal Vit D was noted in only 7/113 (6.2%) patients. Sixteen of the 20 patients (80%) with Vit D deficiency, and 38/86 (44.2%) with insufficiency had an abnormal MPI SPECT. In contrast, only 1/7 (14.3%) patients with sufficient Vit D levels had an abnormal MPI SPECT. The Mann-Whitney U-test showed that ischemia reduced the values of Vit D. Correlation analysis showed a negative association of Vit D levels with SSS (rho = -0.232, p = 0.014) and SRS (rho = -0.250, p = 0.008). Further evaluation with a Vit D cut off 20 ng/mL retrieved no statistical significance. Finally, Vit D and gender were independently associated with myocardial ischemia. Conclusions: Low Vit D levels may represent a risk factor for myocardial ischemia.
Subject(s)
Coronary Artery Disease , Myocardial Ischemia , Myocardial Perfusion Imaging , Vitamin D Deficiency , Female , Humans , Male , Myocardial Ischemia/diagnostic imaging , Myocardial Ischemia/epidemiology , Myocardial Ischemia/etiology , Retrospective Studies , Risk Factors , Vitamin D Deficiency/complications , Vitamin D Deficiency/epidemiologyABSTRACT
Limbic encephalitis is an inflammatory process involving the limbic structures of the brain, manifested with short-term memory deficits, confusion, depression and seizures. It is usually a paraneoplastic condition but it may also appear as a nonparaneoplastic syndrome. Patients with this condition may exhibit a variety of antibodies in their serum or/and cerebrospinal fluid targeting basement membrane components that bind to a variety of neurotransmitter receptors such as α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and GABA B and proteins associated to the ion channels such as LGI1, Caspr2 or intracellular components. Flurodeoxyglucose PET/computed tomography usually demonstrates increased uptake in the limbic structures, and it may reveal the site of the primary tumor. Treatment consists of tumor removal if possible. Symptomatic treatment includes steroids, gamma immune globulin, plasma exchange, immunosuppressive therapies and anti-epileptic drugs. Prognosis is better when it is associated with antibodies against basement membrane rather than intracellular antibodies.
Subject(s)
Limbic Encephalitis/diagnosis , Limbic Encephalitis/therapy , Neoplasms/complications , Anticonvulsants/therapeutic use , Autoantibodies/blood , Fluorodeoxyglucose F18 , Humans , Limbic Encephalitis/complications , Limbic Encephalitis/immunology , Positron Emission Tomography Computed Tomography , Seizures/drug therapySubject(s)
Electronic Health Records , Obesity , Body Mass Index , Comorbidity , Humans , Obesity/epidemiology , Risk FactorsSubject(s)
Adenoma , Parathyroid Neoplasms , Adenoma/surgery , Calcium , Humans , Parathyroid Hormone , Parathyroid Neoplasms/surgery , ParathyroidectomyABSTRACT
Osteosarcoma (OS) is the most frequent bone-forming malignancy in children and adolescents. Concerning its molecular landscape, there is no a direct relationship with a specific gene, but a combination of genetic events. A broad spectrum of activated oncogenes and downregulated suppressor genes has been already explored and considered crucial for its progressive pathogenesis. Mechanisms of gene deregulation include amplifications, point mutations, allelic losses and also epigenetic abnormalities such as aberrant promoter methylation. Although a significant progress in understanding the molecular nature of the OS has been achieved, its aggressive phenotype - characterized by high metastatic potential - remains unexplored. Novel targeted therapeutic strategies include monoclonal antibodies (mABs) and also tyrosine-kinase inhibitors (TKIs). Additionally, sophisticated and innovative diagnostic techniques, such as 18 fluorodeoxyglucose positron emission tomography plus CT (18F-FDG/PET/CT), provide critical data regarding its biological behavior. In the current paper, we present novel molecular and metabolic advances by analyzing OS genetic profile and biochemical microenvironment.
Subject(s)
Bone Neoplasms/genetics , Molecular Targeted Therapy , Neoplasm Proteins/genetics , Osteosarcoma/genetics , Tumor Suppressor Proteins/genetics , Antibodies, Monoclonal/therapeutic use , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/metabolism , Bone Neoplasms/therapy , Fluorodeoxyglucose F18/therapeutic use , Gene Expression Regulation, Neoplastic/genetics , Humans , Neoplasm Metastasis , Neoplasm Proteins/metabolism , Oncogenes/genetics , Osteosarcoma/diagnostic imaging , Osteosarcoma/metabolism , Osteosarcoma/therapy , Positron Emission Tomography Computed Tomography , Protein Kinase Inhibitors/therapeutic use , Tumor Suppressor Proteins/metabolismSubject(s)
Osteoporosis, Postmenopausal , Osteoporosis , Breast Feeding , Female , Humans , Parity , Pregnancy , Time FactorsSubject(s)
Glucocorticoids/adverse effects , Methylprednisolone/adverse effects , Multiple Sclerosis/drug therapy , Myocardial Ischemia/chemically induced , Myocardial Ischemia/diagnostic imaging , Myocardial Perfusion Imaging , Coronary Angiography , Female , Glucocorticoids/administration & dosage , Humans , Methylprednisolone/administration & dosage , Middle AgedSubject(s)
Coronary Artery Disease , Anxiety , Coronary Artery Disease/epidemiology , Depression , Humans , Risk FactorsABSTRACT
BACKGROUND: Identification of aetiology for fever of unknown origin (FUO) is challenging, due to the high rates of undiagnosed cases. The current diagnostic approach includes initially first-line procedures such as general examination and various laboratory tests and basic imaging techniques followed by second-line tests such as more advanced imaging techniques including (18)F fluorodeoxyglucose positron emission tomography (FDG PET) and tissue biopsies. If no diagnosis is obtained, more invasive measures may be in order such as liver biopsy and exploratory laparotomy. MATERIALS AND METHODS: This review article is based on the relative published material found on MEDLINE and PubMed up to August 2014. We looked for the terms 'fever of unknown origin, FDG PET' in combination with 'cancer, infection and autoimmune disease'. RESULTS: Several clinical studies have investigated the utility of the FDG PET during the diagnostic approach of FUO. Recent evidence suggests that FDG PET has the advantage of total body imaging and may depict all common causes of FUO such as infections, noninfectious inflammatory causes and tumours because they all exhibit glucose hypermetabolism. Depiction of an abnormal lesion on FDG PET could guide clinicians to the next diagnostic procedure (another imaging method, culture, biopsy or surgery) to establish the diagnosis. CONCLUSIONS: Emerging evidence suggests that FDG PET, when available, may provide critical diagnostic information early during evaluation of FUO.
Subject(s)
Fever of Unknown Origin/diagnostic imaging , Fluorodeoxyglucose F18 , Positron-Emission Tomography/methods , Radiopharmaceuticals , Autoimmune Diseases/complications , Autoimmune Diseases/diagnostic imaging , Epidemiologic Methods , Fever of Unknown Origin/etiology , Humans , Multimodal Imaging/methods , Neoplasms/complications , Neoplasms/diagnostic imaging , Tomography, X-Ray Computed/methodsABSTRACT
Mobile phone use has been discussed over the last few decades with increased risk for intracranial tumors. The majority of studies have been conducted on gliomas and meningiomas. Although some case-control studies have found a positive association between the use of mobile phones and the risk of tumors, other studies have reported no significant association. A possible long-term mobile phone use may lead to increased risk however, the evidences are not yet conclusive and further studies are needed. In the present study we reviewed the current evidence for the association between mobile phone use and risk for intracranial tumors.